Israel Englander Bio N Tech Se Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Bio N Tech Se stock. As of the latest transaction made, Millennium Management LLC holds 50,200 shares of BNTX stock, worth $5.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,200

Previous 22,100 127.15%

Holding current value

$5.43 Million

Previous $1.78 Million 235.89%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $49.4 Million - $78.5 Million	-630,021 Reduced 96.32%	24,095 $2.86 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $37.5 Million - $48 Million	466,472 Added 248.59%	654,116 $52.6 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $1.93 Million - $2.44 Million	21,691 Added 13.07%	187,644 $17.3 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $16.8 Million - $20.9 Million	-185,057 Reduced 52.72%	165,953 $17.5 Million
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $12.3 Million - $15.5 Million	-119,866 Reduced 25.46%	351,010 $37.9 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $42.8 Million - $53.6 Million	348,853 Added 285.89%	470,876 $58.7 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $4.23 Million - $6.65 Million	35,738 Added 41.42%	122,023 $18.3 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $42.1 Million - $60.4 Million	-330,028 Reduced 79.27%	86,285 $11.6 Million
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $19.1 Million - $28.8 Million	154,877 Added 59.24%	416,313 $62.1 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $30.4 Million - $55.8 Million	240,607 Added 1155.15%	261,436 $44.6 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $62.6 Million - $105 Million	-289,001 Reduced 93.28%	20,829 $5.37 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $15.2 Million - $32.9 Million	73,611 Added 31.16%	309,830 $84.6 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $16.3 Million - $34.7 Million	143,690 Added 155.29%	236,219 $52.9 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $8.28 Million - $11.5 Million	-96,537 Reduced 51.06%	92,529 $10.1 Million
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $5.72 Million - $10.2 Million	-78,664 Reduced 29.38%	189,066 $15.4 Million
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $5.76 Million - $10.4 Million	99,632 Added 59.27%	267,730 $18.5 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $6.19 Million - $10.7 Million	160,425 Added 2090.77%	168,098 $11.2 Million
Q1 2020 May 14, 2020	SELL	$28.55 - $92.0 $3.78 Million - $12.2 Million	-132,532 Reduced 94.53%	7,673 $448,000
Q4 2019 Feb 14, 2020	BUY	$12.75 - $36.91 $1.79 Million - $5.17 Million	140,205 New	140,205 $4.75 Million

Others Institutions Holding BNTX

# of Institutions

356

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account